United States · FDA National Drug Code directory
Atropine Sulfate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0517-1004_1c500ed9-94a9-472c-bfb7-50e1fcfc31fb
- Product NDC
- 0517-1004
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ATROPINE SULFATE
- Labeler
- American Regent, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220802
- Source listing expiry
- 20261231
Source-listed ingredients
- ATROPINE SULFATE — .4 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL, GLASS in 1 TRAY (0517-1004-25) / 1 mL in 1 VIAL, GLASS (0517-1004-01) · 0517-1004-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →